Preterm birth is associated with high rates of cognitive and behavioral difficulties that usually become apparent at school age and can significantly affect the child's learning and social abilities ([@R1], [@R2]). Long-term morbidities are related to the increased frequency of depression, posttraumatic stress, and attachment disorders that have been described in parents ([@R3]--[@R5]). Neurodevelopmental care has the potential to support the brain development of preterm babies during hospital stay and to enhance parental competencies and well being ([@R6]--[@R9]). The concept encompasses a wide range of environmental and behavioral strategies, including protection of infant sleep, pain management, skin-to-skin (kangaroo) care (KC), feeding support with breast-feeding (BF) encouragement, reduction of environmental stressors, and integration of parents in their child's care ([@R10]).

Neurodevelopmental care is advocated by parents' associations ([@R11]), but uptake varies widely around the world. Implementation remains difficult ([@R12], [@R13]) especially for nurses who often feel challenged ethically and may experience moral distress ([@R14]). Most neonatal units incorporate specific aspects of neurodevelopmental care, such as reduction of noise or protection against direct light, whereas some implement complex programs, such as Newborn Individualized Developmental Care and Assessment Program (NIDCAP) ([@R15]), which aims to integrate all aspects of neurodevelopmental care based on the neurobehavioral readiness of the individual baby in a family-centered approach. The role of such programs to support implementation is vigorously debated. They are embedded in the complexity theory, which identifies the multilayered reality of healthcare and the relationships between macrostructures and microlevel behavior of a system ([@R16]). In practice, it requires understanding of the interactions between professionals, neonates, and parents in the organization of care ([@R17]). Factors influencing the implementation of neurodevelopmental care in neonatal clinical practice are poorly understood, and evidence-based strategies for accomplishing changes are needed. The most comprehensive area-based studies carried out so far have been based on professional reports of policies and showed large variation between and within countries ([@R18], [@R19]). It is not known, however, to what extent reported policies were associated with clinical care of individual patients.

The EPIPAGE-2 cohort study was designed to survey neonatal unit policies and measure survival and morbidity after very preterm birth in 2011 in France and to explore variations in clinical practice ([@R20]). Neurodevelopmental care data were specifically recorded both at unit and patient levels, thus providing unique opportunities to explore relationships between policies and practices. This article aims first to describe neonatal ICU (NICU) policies regarding several measures of neurodevelopmental care in France in 2011 and to gauge change by comparing them with the 2004 data collected in the same units by the European Science Foundation (ESFs) survey ([@R18], [@R19]). KC and BF have high levels of evidence ([@R21]--[@R24]); they were examined for individual infants with intention to highlight strategies to prioritize for improving care at the national level.

MATERIALS AND METHODS
=====================

Population
----------

EPIPAGE-2 is a national, prospective population-based study of very preterm neonates, with planned follow-up of survivors up to 12 years old ([@R20]). Data for all births occurring between 22 and 31 completed weeks of gestational age (GA) during the EPIPAGE-2 inclusion period were collected prospectively in 25 participating French regions. All level III NICUs in these areas (*n* = 66) participated in the study. Among the 3,963 neonates born alive, 3,274 survived to discharge. Neurodevelopmental care provision was analyzed for infants admitted to NICUs during the first week of life and surviving to discharge (*n* = 3,005).

Data Sources
------------

We used structured questionnaires to collect information at NICU level (policies) and for each infant (practices). The NICU questionnaire, completed by a senior pediatrician, collected general information, such as affiliation with a university teaching hospital and number of very preterm neonates admitted per year. Data were also collected on several neurodevelopmental care measures (for details, see **ESM-1**, Supplemental Digital Content 1, <http://links.lww.com/PCC/A283>). Missing data were obtained by telephone before analysis. The response rate was 100%. Information about neurodevelopmental care training was cross-checked with the declaration of French trainers.

The neonatal questionnaire provided data on the age of the baby at the first KC, feeding support defined as swaddling and/or sucking and/or KC during a feed, breast milk expression by the mother defined as BF initiation, and protection against light and noise.

Data Analysis
-------------

We first described the characteristics of the 66 level III NICUs and their neurodevelopmental care policies. We analyzed the evolution of neurodevelopmental care policies between 2004 and 2011 by comparing information available from NICUs that participated in both the ESFs and EPIPAGE-2 (*n* = 43). We then described neurodevelopmental care practices at the infant level. The main outcome measures were KC and BF initiation during the first week of life assessed as binary variables (yes/no), and we correlated them with KC and BF policies. We used available variables in the NICU questionnaires to calculate aggregated indices, based on existing guidelines ([@R25], [@R26]), reflecting the extent of KC or BF supportive policies. We classified units into three groups for these two indicators, with group 1 having the lowest level of implementation and group 3 aiming for the highest level (**supplemental file**, Supplemental Digital Content 1, <http://links.lww.com/PCC/A283>). We then carried out multilevel multiple logistic analysis to investigate the association between NICUs characteristics and infant outcomes, taking into account the hierarchical nature of the database with infants (level 1) nested within NICUs (level 2).

Variables considered as potential confounders at infant level were GA, single or multiple pregnancies, birthweight below 10th centile, and maternal nationality, education, and employment before pregnancy. Maternal education and employment before pregnancy were highly correlated within each other, so we entered only maternal employment, with less than 5% missing values, in the final regression models. At unit level, variables of interest were KC or BF policies and training in neurodevelopmental care.

We first estimated a random intercept model without any predictor variables (model 1) to obtain the baseline unit-level variance (var^(1)^). In model 2, we included infant characteristics to investigate the association of infant-level variables with KC and BF initiation and to estimate the residual unit-level variation after adjustment for infant-level variables (var^(2)^). We used the proportional change in variance (PCV = \[var^(1)^ -- var^(2)^\]/var^(1)^) to assess the extent to which units' differences in KC and BF initiation may be explained by differences in the distribution of infant-level characteristics across units. In model 3, we added unit characteristics after adjustment for infant-level variables to investigate the association of policies and training with KC and BF initiation and calculated the PCV between model 1 and model 3 (PCV = \[var^(1)^ -- var^(3)^\]/var^(1)^). As a sensitivity analysis, we used multiple (*n* = 12) imputations by chained equations to impute missing data. Multiple imputation models included all baseline variables and outcomes. Estimates were combined across imputed data sets using Rubin rules.

Analyses were performed using SAS version 9·3 (SAS, Cary, NC); the SAS GLIMMIX and the multiple imputation procedures were used for multilevel logistic modeling and imputations. Chi-square test, McNemar test for pairwise comparison, and Fisher exact test were used as appropriate. *p* value less than 0.05 was considered statistically significant.

Ethics
------

Recruitment and data collection for the EPIPAGE-2 study occurred only after families had received information and agreed to participate. Data for this study were extracted from the national database. Ethics approval was obtained from appropriate French ethics committees ([@R20]).

RESULTS
=======

Neurodevelopmental Care Policies and Changes Since 2004
-------------------------------------------------------

**Table [1](#T1){ref-type="table"}** shows characteristics and policies of the 66 level III NICUs in 2011. Most NICUs (91%) admitted over 50 neonates born less than 32 weeks of GA per year. Unlimited parental access over 24 hours was allowed in 89%. However, only seven of 66 NICUs (11%) simultaneously offered beds, bathrooms, and facilities for meals inside the unit. KC was offered routinely to mothers in 64% and to fathers in 53% of units. A professional dedicated to BF was available in 88% of the units, but in 39 of 58 cases, he/she had no formal training in human lactation. Overall, 40 NICUs (61%) were in KC group 3, whereas this was true for only seven units (11%) for BF. Neurodevelopmental care training programs were reported as NIDCAP ([@R15]), sensory-motor program ([@R27]), and introductory course. The 2-day introductory course was delivered by NIDCAP professionals in 13 of 18 units and was attended by a substantial number of professionals from the team. Forty-four percent of units had not implemented any neurodevelopmental care training program.

###### 

Characteristics and Neurodevelopmental Care Policies of French Level III Neonatal ICUs in 2011
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**Table [2](#T2){ref-type="table"}** shows changes between 2004 and 2011 in the 43 NICUs participating to both the ESFs and EPIPAGE-2. The number of units allowing visits over 24 hours, having a bed for parents inside units and routinely encouraging KC, significantly increased. The use of standardized neurobehavioral assessment decreased; in 2004, this was used in 21 units (49%) compared with 12 (28%) in 2011.
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Evolution of Neurodevelopmental Care Policies for French Level III Neonatal ICUs Between 2004 and 2011

![](pcc-17-957-g002)

Neurodevelopmental Care Practices During the First Week of Life
---------------------------------------------------------------

Neurodevelopmental care practices were analyzed for infants born at 23--26 and 27--31 weeks of GA (**Table [3](#T3){ref-type="table"}**). KC initiation was reported for 61% of the neonates, with important differences by the GA group; BF initiation was consistent (62%) across both GA groups. Less than 10% of neonates were exposed to the breast, and 39% had parents involved in feeding support. Protection against direct light was common, and around one third of the babies were hospitalized in a single room.
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Neurodevelopmental Care Practices During the First Week of Life by Gestational Age for Neonates Admitted to French Level III Neonatal ICUs in 2011
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Factors Associated With KC and BF Initiation
--------------------------------------------

### KC Initiation.

The proportions of neonates initiating KC (**Fig. [1](#F1){ref-type="fig"}**) in the three groups reflecting unit level KC implementation were 39% (95% CI, 32--43) in group 1, 55% (95% CI, 51--57), in group 2, and 68% (95% CI, 64--69) in group 3 (*p* \< 0.001). **Table [4](#T4){ref-type="table"}** shows the multilevel regression analysis, which was carried out on 2,636 completed cases. Compared with neonates included in the analysis, those excluded because of missing data were younger (*p* = 0.02), required less mechanical ventilation (*p* = 0.002), and were more often admitted to KC group 1 and 2 units (*p* \< 0.001) or units without any neurodevelopmental care training (*p* = 0.03).
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Multilevel Logistic Regression Analysis of Infant and Unit Factors Associated With Kangaroo Care Initiation During the First Week of Life in French Level III Neonatal ICUs in 2011
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![Proportion of kangaroo care (KC) and breast-feeding (BF) initiation among the neonates admitted in the three groups of units defined according to their policies.](pcc-17-957-g005){#F1}

Variance in proportion of KC initiation across units was statistically significant (model 1; unit-level variance, var^(1)^ = 1.07; *p* \< 0.001). Differences in infants' characteristics across units could not explain unit-level variations in KC initiation that remained significant and slightly increased after adjustment for patient-level variables (model 2). GA was the main factor associated with KC initiation (odds ratio \[OR\], 5.8; 95% CI, 4.5--7.5 for neonates born at 27--31 weeks of GA compared with neonates born at 23--26 weeks of GA) and, to a lesser extent, type of pregnancy, intrauterine growth, and maternal employment. The inclusion of unit variables (model 3) reduced the variance (var^(3)^ = 0.64; *p* \< 0.001). Unit-level variables explained 40% of unit-level variation in KC initiation across units. After adjustment for infant-level factors, unit policies and training were significantly associated with KC initiation (OR, 3.3; 95% CI, 1.5--7.4 for KC group 3 compared with group 1 and OR, 3.5; 95% CI, 1.8--7.0 for NIDCAP training compared with no training).

### BF Initiation.

The proportion of neonates whose mothers started to express milk was higher in the group of units with higher level of BF policies (group 3) (*p* \< 0.001) (Fig. [1](#F1){ref-type="fig"}).

The multilevel regression analysis (2,635 completed cases) is reported in **Table [5](#T5){ref-type="table"}**. No difference between neonates included and excluded from the analysis was observed. As the rate of BF initiation was similar in BF group 1 and 2 units, data for these 2 groups were aggregated and compared with group 3 data.
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Variation in proportion of BF initiation across units was statistically significant. Adjustment for patient-level variables (model 2) slightly increased this variance. Maternal employment before pregnancy was the main factor associated with BF initiation (OR, 1.3; 95% CI,1.1--1.6). Inclusion of unit-level variables (model 3) slightly reduced the variance in BF initiation across units. After adjustment for infant-level factors, group 3 units were significantly associated with BF initiation (OR, 1.8; 95% CI, 1.0--3.2).

For both models, results using multiple imputations were consistent with those from complete case analyses (data not shown).

DISCUSSION
==========

This study is the first to investigate dissemination of neurodevelopmental care at country level and the impact of structured programs on this dissemination. In this large population-based French sample, we found that almost 90% of NICUs allowed unlimited parental presence and over half routinely offered KC to both parents. Policies that support parents increased significantly between 2004 and 2011, and importantly, units with more evidence-based KC or BF policies were significantly more likely to apply these interventions. In addition, structured programs, such as NIDCAP, seemed to enhance KC and, to a lesser extent, BF initiation.

Areas explored have ethical and legal support or have received a high level of evidence. Not separating neonates and parents has been advocated internationally ([@R28]--[@R30]) and in several national recommendations, including France ([@R31]). KC is highly recommended even in high-income environments ([@R25]). Breast milk has many proven benefits for preterm newborns ([@R23], [@R24]). However, difficulties in translating research findings and recommendations into clinical practice are well known ([@R32]), and many studies point out the underutilization of appropriate research-based knowledge in clinical practice ([@R33]). In our study, large variabilities between units were observed with gaps between policies and opportunities for implementation. Open access visiting policies were nearly universal, but facilities for parents were lacking. KC was widespread but with frequent restrictions. Professional support for BF was available in most units, but one third of these professionals did not receive any formal training in human lactation. Although policies had positively evolved since 2004, they were still less developed than those described in countries with the highest uptake in 2004, such as Denmark, Sweden, and the United Kingdom for parental access or Denmark, Sweden, and the Netherlands for KC ([@R18], [@R19]). It is generally stated that it takes an average of 17 years for research evidence to reach widespread clinical practice ([@R34]), and the evolution described in our study can be considered as positive. On the other hand, a better understanding of factors that facilitate the translation of research into practice is necessary. Public policies and funding, together with stakeholder groups, have effectively promoted family-centered and neurodevelopmental care program at national levels ([@R35], [@R36]), and countries that showed greater implementation of neurodevelopmental care in 2004, compared with France, are also described as having strong national policies or adequate governmental funding ([@R11]). In comparing the 2004 and 2011 French data, areas of improvement were mainly those that require strong supportive leadership in the NICUs rather than additional resources and clinical-administrative partnerships. However, all aspects of neurodevelopmental care are embedded in complex healthcare systems ([@R16]) where change is dependent on macro- and microlevel organization. For example, multifaceted interventions are needed to implement KC, even in countries with many facilitators, such as Sweden ([@R14], [@R38]). In our cohort, initiation of KC was associated with maternal and neonatal characteristics, but a substantial part of the variance among units was explained by unit policies and training. Higher levels of supportive policies were associated with greater KC initiation, but specific neurodevelopmental care training aiming to support KC ([@R15]) strengthened the implementation. Guidelines do not implement themselves ([@R39]), and our results support this assumption; policies increased KC uptake, but structured training based on NIDCAP theory strengthened the impact of policies. However, we do not know if the "dose" of KC received by the infants in those units was influenced by training. Units with training in the sensory-motor development program ([@R27]) were less likely to initiate KC during the first week of life. The two programs have different theoretical frameworks with the NIDCAP, emphasizing relationship-based care with guidance for system change ([@R9], [@R15]), whereas the sensory-motor program is more task focused.

Not surprisingly, BF policies were more strongly associated with BF initiation than neurodevelopmental care training, which uses newborn neurobehavioral observation to facilitate transition from tube to oral feeds ([@R39]). BF initiation requires knowledge of the physiology of human lactation, and units with trained professionals in lactation may have higher competencies to support early breast milk expression.

The lack of shared knowledge on newborn neurobehavioral observation might hold back the dissemination of beneficial practices. A U.K. survey indicated that having staff trained in newborn observation positively affected developmental care uptake in units ([@R40]). In our cohort, less than 30% of units used a scale to assess newborn neurobehavior. Surprisingly, this number decreased between 2004 and 2011, possibly because the practice is time consuming and neuroimaging has increased ([@R41], [@R42]).

The French situation is not unique in Europe. A gap between North and South has been described for neurodevelopmental care implementation and more generally for parental role in NICUs, suggesting social and cultural differences ([@R18], [@R19]). However, a study in Spain highlighted how structured programs based on the NIDCAP framework can bridge this gap, with staff perceptions after training becoming similar to those described in Northern Europe ([@R43]). Several models designed to improve neonatal neurodevelopmental care have been published, all of which incorporate neurobehavioral observations of neonates are shared with parents ([@R15], [@R44]--[@R46]), and some of them have investigated the impact on outcome ([@R47], [@R48]). However, they were evaluated in a research context, and no data are available on their dissemination at national level. The number of neurodevelopmental care programs available in France was limited, but we were able to investigate modes of training, based on different strategies for implementation.

This study has limitations. Although KC and BF initiation are two core neurodevelopmental measures, they do not cover a full range of neurodevelopmental care practices. However, both have large developmentally supportive effects, promoting parental participation and attachment, as well as physiologic stability, preservation of sleep, and analgesia ([@R21], [@R22], [@R26]). It might have been interesting to study the "dose" of KC received by each infant, as well as BF at discharge, but practices during the first week of life were more easily explored at population level, and dose is usually related to early initiation ([@R49]). The observational design of the study allowed us to establish potential associations rather than causal factors. NIDCAP seemed to enhance early KC initiation and, to a lesser extent, BF initiation, but we were not able to describe the level of implementation in each unit, and variability among units could also be explained by patient or unit characteristics, such as nurse-to-patient ratio, that we did not control for. Finally, data for 12% of the neonates were missing and excluded from final analysis. Their exclusion might have altered the strength of associations, but this was not observed after multiple imputations.

The strengths of the study are substantial. Data were recorded at population level, with a high rate of completeness for NICU questionnaires. The large sample size assures representativeness and power of the study. Questions in the ESFs and the French survey were worded exactly the same, facilitating the comparison between the two studies. Availability of unit policies and parallel data at the level of individual babies allowed us to investigate the impact of policies on clinical care, taking into account maternal and infant characteristics. The significant associations that were found between policies and practices suggest that these data could help to define national guidelines and realistic goals to improve neonatal services.

CONCLUSIONS
===========

In Europe, neurodevelopmental care implementation is advocated by parent associations. It has been increasingly recognized that context is a critical element in the successful implementation of evidence into practice. Unit policies seem essential for neurodevelopmental care implementation, but conceptual models to guide clinical care seem to affect practices and strengthen policies. This study contributes to a better understanding of factors that effectively spread the implementation of neurodevelopmental care measures and factors that need to be explored for a wider range of strategies and in different cultural backgrounds.
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